uniQure N.V. Files 2024 10-K
Ticker: QURE · Form: 10-K · Filed: Feb 27, 2025 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | 10-K |
| Filed Date | Feb 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, biotechnology, gene-therapy
TL;DR
uniQure dropped its 2024 10-K. Full financials and risks out now.
AI Summary
uniQure N.V. filed its 2024 10-K on February 27, 2025, reporting its financial performance for the fiscal year ending December 31, 2024. The company, a biopharmaceutical firm focused on gene therapies, provided details on its operations, financial condition, and risk factors. Specific financial figures for the fiscal year 2024, including revenue, expenses, and net loss, are detailed within the filing.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of uniQure's financial health and strategic direction for the past fiscal year, crucial for understanding the company's progress in developing gene therapies.
Risk Assessment
Risk Level: medium — As a biotechnology company, uniQure faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (Reporting period for the 10-K)
- 2025-02-27 — Filing Date (Date the 10-K was submitted to the SEC)
Key Players & Entities
- uniQure N.V. (company) — Filer of the 10-K
- 2024-12-31 (date) — Fiscal year end
- 2025-02-27 (date) — Filing date
- 0001590560 (company) — Central Index Key for uniQure N.V.
FAQ
What is uniQure N.V.'s primary business focus as detailed in the 10-K?
The filing indicates uniQure N.V. is focused on gene therapies, as suggested by its SIC code for Pharmaceutical Preparations [2834] and its business operations.
When did uniQure N.V. file its 10-K for the fiscal year ending December 31, 2024?
uniQure N.V. filed its 10-K on February 27, 2025.
What is the Central Index Key (CIK) for uniQure N.V.?
The CIK for uniQure N.V. is 0001590560.
What was uniQure N.V.'s former company name?
The former company name for uniQure N.V. was uniQure B.V., with a name change date of October 30, 2013.
Where is uniQure N.V. headquartered?
uniQure N.V. is headquartered in Amsterdam, with a business address at Paasheuvelweg 25A, 1105 BP.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 27, 2025 regarding uniQure N.V. (QURE).